相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A predicted dimer-based polymorph of 10,11-dihydrocarbamazepine (Form IV)
Jean-Baptiste Arlin et al.
CRYSTENGCOMM (2010)
Anion-switchable supramolecular gels for controlling pharmaceutical crystal growth
Jonathan A. Foster et al.
NATURE CHEMISTRY (2010)
Modelling organic crystal structures using distributed multipole and polarizability-based model intermolecular potentials
Sarah L. Price et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2010)
Computed Crystal Energy Landscapes for Understanding and Predicting Organic Crystal Structures and Polymorphism
Sarah (Sally) L. Price
ACCOUNTS OF CHEMICAL RESEARCH (2009)
A catemer-to-dimer structural transformation in cyheptamide
A. J. Florence et al.
CRYSTENGCOMM (2008)
Two-dimensional similarity between forms I and II of cytenamide, a carbamazepine analogue
A. J. Florence et al.
CRYSTENGCOMM (2008)
Targeted crystallisation of novel carbamazepine solvates based on a retrospective Random Forest classification
Andrea Johnston et al.
CRYSTENGCOMM (2008)
Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine
Scott L. Childs et al.
CRYSTENGCOMM (2008)
Polymorph control: past, present and future
Antonio Llinas et al.
DRUG DISCOVERY TODAY (2008)
One-solvent polymorph screen of carbamazepine
A. Getsoian et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
10,11-dihydrocarbamazepine (form III)
Charlotte K. Leech et al.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE (2007)
Crystal engineering: A holistic view
Gautam R. Desiraju
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
An automated parallel crystallisation search for predicted crystal structures and packing motifs of carbamazepine
Alastair J. Florence et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
An orthorhombic polymorph of 10,11-dihydrocarbamazepine
WTA Harrison et al.
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS (2006)
Control and prediction of packing motifs: a rare occurrence of carbamazepine in a catemeric configuration
A. J. Florence et al.
CRYSTENGCOMM (2006)
Structural studies of the polymorphs of carbamazepine, its dihydrate, and two solvates
RK Harris et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2005)
Cultivating crystal forms
J Bernstein
CHEMICAL COMMUNICATIONS (2005)
Exercises in prognostication: Crystal structures and protein folding
JD Dunitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Crystal engineering of the composition of pharmaceutical phases:: Multiple-component crystalline solids involving carbamazepine
SG Fleischman et al.
CRYSTAL GROWTH & DESIGN (2003)
Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization
SL Morissette et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I
AL Grzesiak et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Polymorphism - Integrated approach from high-throughput screening to crystallization optimization
R Hilfiker et al.
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY (2003)
Form IV of carbamazepine
MD Lang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)